Načítá se...
mTOR inhibitors in cancer therapy
The mammalian target of rapamycin, mTOR, plays key roles in cell growth and proliferation, acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 (mTORC1/2). mTORC1 signaling is switched on by several oncogenic signaling pathways and is accordingly hyperactive in the...
Uloženo v:
| Vydáno v: | F1000Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
F1000Research
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007757/ https://ncbi.nlm.nih.gov/pubmed/27635236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9207.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|